JP2003292492A5 - - Google Patents

Download PDF

Info

Publication number
JP2003292492A5
JP2003292492A5 JP2003020506A JP2003020506A JP2003292492A5 JP 2003292492 A5 JP2003292492 A5 JP 2003292492A5 JP 2003020506 A JP2003020506 A JP 2003020506A JP 2003020506 A JP2003020506 A JP 2003020506A JP 2003292492 A5 JP2003292492 A5 JP 2003292492A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
optionally
hydrogen atom
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003020506A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003292492A (ja
JP5072166B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2003020506A priority Critical patent/JP5072166B2/ja
Priority claimed from JP2003020506A external-priority patent/JP5072166B2/ja
Publication of JP2003292492A publication Critical patent/JP2003292492A/ja
Publication of JP2003292492A5 publication Critical patent/JP2003292492A5/ja
Application granted granted Critical
Publication of JP5072166B2 publication Critical patent/JP5072166B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003020506A 2002-01-30 2003-01-29 チエノピリミジン化合物、その製造法および用途 Expired - Lifetime JP5072166B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003020506A JP5072166B2 (ja) 2002-01-30 2003-01-29 チエノピリミジン化合物、その製造法および用途

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2002022034 2002-01-30
JP2002022034 2002-01-30
JP2002-22034 2002-01-30
JP2003020506A JP5072166B2 (ja) 2002-01-30 2003-01-29 チエノピリミジン化合物、その製造法および用途

Publications (3)

Publication Number Publication Date
JP2003292492A JP2003292492A (ja) 2003-10-15
JP2003292492A5 true JP2003292492A5 (https=) 2006-01-26
JP5072166B2 JP5072166B2 (ja) 2012-11-14

Family

ID=29253350

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003020506A Expired - Lifetime JP5072166B2 (ja) 2002-01-30 2003-01-29 チエノピリミジン化合物、その製造法および用途

Country Status (1)

Country Link
JP (1) JP5072166B2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1591446B1 (en) 2003-01-29 2013-03-06 Takeda Pharmaceutical Company Limited Thienopyrimidine compounds and use thereof
JP2008094846A (ja) * 2003-01-29 2008-04-24 Takeda Chem Ind Ltd チエノピリミジン化合物およびその用途
EP1847541A4 (en) * 2005-02-03 2009-12-30 Takeda Pharmaceutical CONDENSED PYRIMIDINE DERIVATIVE AND USE THEREOF
HRP20191679T1 (hr) * 2013-10-30 2019-12-13 Shanghai hengrui pharmaceutical co ltd Derivati pirazolopirimidona ili pirolotriazona, postupak pripreme jednakih i njihove farmaceutske uporabe
CA2978223A1 (en) * 2015-02-26 2016-09-01 Takeda Pharmaceutical Company Limited Formulations of n-(4-(1-(2,6-difluorobenzyl)-5-((dimethyl amino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-n'-methoxyurea
AR106472A1 (es) * 2015-10-26 2018-01-17 Gilead Apollo Llc Inhibidores de acc y usos de los mismos
BR112022023937A2 (pt) 2020-05-29 2022-12-27 Myovant Sciences Gmbh Formas de dosagem oral sólidas de combinação de antagonistas do hormônio liberador de gonadotropina
CN113717149A (zh) * 2021-09-29 2021-11-30 成都伊诺达博医药科技有限公司 一种瑞卢戈利关键中间体及其制备方法

Similar Documents

Publication Publication Date Title
CA2514407A1 (en) Thienopyrimidine compounds and use thereof
JP7317028B2 (ja) 抗ガン剤として有用な置換キナゾリン誘導体と置換ピリドピリミジン誘導体
AU2011257336B2 (en) The use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc).
CN113474337A (zh) 作为fgfr抑制剂用于治疗癌症的7-((3，5-二甲氧基苯基)氨基)喹喔啉衍生物
JP2006516250A (ja) カスパーゼ活性化剤およびアポトーシス誘導物質としての３，５−二置換−［１，２，４］−オキサジアゾールおよびそれらの誘導体ならびにそれらの使用
JP2008525498A5 (https=)
Tamayo et al. Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase
RU2015106787A (ru) Замещенные пирролы, активные в качестве ингибиторов киназ
US20090131414A1 (en) Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis c
US20150065525A1 (en) Methods for improving diaphragm function
RU2004106783A (ru) Производные 4-амино-6-фенилпирроло[2, 3] пиримидина
RU2013132758A (ru) ЗАМЕЩЕННЫЕ N-(1H-ИНДАЗОЛ-4-ИЛ) ИМИДАЗОЛ [1,2-a]ПИРИДИН-3- КАРБОКСАМИДНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ РЕЦЕПТОРНОЙ ТИРОЗИНКИНАЗЫ III ТИПА
JP2003292492A5 (https=)
JP2006511491A5 (https=)
JP2005529089A5 (https=)
KR20160012196A (ko) 피라졸로피롤리딘 유도체 및 질환의 치료에서의 그의 용도
JPWO2008001886A1 (ja) オーロラ（Ａｕｒｏｒａ）阻害剤
EP2646428A1 (en) Heterocyclic derivates preparation processes and medical uses thereof
EP2037924A2 (en) Bicyclic heteroaryl inhibitors of pde4
CN108774232A (zh) 2,3-二氢咪唑并[1,2-c]喹唑啉取代衍生物
JP2000159672A (ja) 硝酸誘発耐性の処置剤
JP2003512467A5 (https=)
JP2007515468A5 (https=)
JP2008525502A5 (https=)
HRP20100651T1 (hr) 5,7-DIAMINOPIRAZOLO[4,3-d]PIRIMIDINI S AKTIVNOSCU INHIBITORA PDE-5